Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Craneware ( (GB:CRW) ) has shared an announcement.
Craneware plc announced the vesting of Long Term Incentive Plan (LTIP) awards for its executives, including the CEO, CFO, CPO, and CLO, following the satisfaction of certain performance conditions. This resulted in the issuance of ordinary shares, with a portion withheld to cover tax liabilities. The net shares received are subject to a two-year holding period. The transaction impacts the company’s total voting rights, with the issued share capital now consisting of 35,542,169 ordinary shares, of which 35,508,820 have voting rights. This adjustment in share distribution and voting rights could influence shareholder interests and company governance.
The most recent analyst rating on (GB:CRW) stock is a Hold with a £2122.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Spark’s Take on GB:CRW Stock
According to Spark, TipRanks’ AI Analyst, GB:CRW is a Neutral.
Craneware’s overall stock score is primarily influenced by its strong financial performance, which is offset by bearish technical indicators and high valuation concerns. The company’s solid balance sheet and revenue growth are positive, but the current market sentiment and valuation metrics suggest caution.
To see Spark’s full report on GB:CRW stock, click here.
More about Craneware
Craneware plc is a leader in healthcare financial performance solutions, focusing on providing software and services that enhance financial and operational performance for healthcare organizations.
Average Trading Volume: 142,065
Technical Sentiment Signal: Hold
Current Market Cap: £715.5M
For a thorough assessment of CRW stock, go to TipRanks’ Stock Analysis page.